A three-dimensional model to analyze drug-drug interactions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ahmed, 1986, Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds, Antiviral Res., 6, 241, 10.1016/0166-3542(86)90005-7
Allen, 1982, Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinofuranosyladenine, Antiviral Res., 2, 203, 10.1016/0166-3542(82)90043-2
Barer, 1986, Quantitation of dye binding by cell monolayers in a microtiter system, Histochem. J., 18, 122, 10.1007/BF01675366
Bauer, 1954, The antiviral and synergistic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice, Br. J. Exp. Pathol., 36, 105
Berenbaum, 1976, Synergy, additivism and antagonism in immunosuppression, Clin. Exp. Immunol., 28, 1
Berenbaum, 1981, Criteria for analyzing interactions between biologically active agents, Adv. Cancer Res., 35, 269, 10.1016/S0065-230X(08)60912-4
Berenbaum, 1985, The expected effect of a combination of agents: the general solution, J. Theor. Biol., 114, 413, 10.1016/S0022-5193(85)80176-4
Berenbaum, 1988, Isobolographic, algebraic, and search methods in the analysis of multiagent synergy, J. Am. Coll. Toxicol., 7, 927, 10.3109/10915818809014524
Carter, 1988, A statistical approach to the construction and analysis of isobolograms, J. Am. Coll. Toxicol., 7, 937, 10.3109/10915818809014527
Carter, 1985, Application of response surface methods for evaluating interactions of soman, atropine, and pralidioxime chloride, Fundam. Appl. Toxicol., 5, S232, 10.1016/0272-0590(85)90133-2
Chan, 1987, Determination by two methods with eight antimicrobial combinations against tobramycin-succeptible and tobramycin-resistant strains of pseudomonas, Diagn. Microbiol. Infect. Dis., 6, 157, 10.1016/0732-8893(87)90101-5
Chou, 1980, Generalized equations for the analysis of inhibitors of mechaelismenton and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors, Eur. J. Biochem., 249, 2928
Chou, 1983, Analysis of combined drug effects: a new look at a very old problem, Trends Pharmacol. Sci., 4, 450, 10.1016/0165-6147(83)90490-X
Chou, 1984, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv. Enzyme Regul., 22, 27, 10.1016/0065-2571(84)90007-4
Elion, 1954, Antagonists of nucleic acid derivatives, J. Biol. Chem., 208, 477, 10.1016/S0021-9258(18)65573-5
Forti, 1986, Objective antiviral assay of the interferons by computer assisted data collection and analysis, Methods Enzymol., 119, 533, 10.1016/0076-6879(86)19073-2
Fraser, 1872, The antagonism between the actions of active substances, Br. Med. J., 457, 10.1136/bmj.2.617.457
Fraser, 1872, The antagonism between the actions of active substances, Br. Med. J., 485, 10.1136/bmj.2.618.485
Fraser-Smith, 1985, Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with gamma interferon against herpes simplex virus type 2 in mice, Antiviral Res., 5, 137, 10.1016/0166-3542(85)90046-4
Freestone, 1985, The need for new antiviral agents, Antiviral Res., 5, 307, 10.1016/0166-3542(85)90001-4
Gessner, 1988, A straightforward method for the study of drug interactions: an isobolographic analysis primer, J. Am. Coll. Toxicol., 7, 987, 10.3109/10915818809014529
Gershwin, 1973, Interaction between drugs using three-dimensional isobolographic interpretation, Arch. Int. Pharmacodyn., 201, 154
Goldwin, 1957, The employment of combinations of drugs in the chemotherapy of neoplasia: a review, Cancer Res., 17, 635
Hall, 1988, Antiviral drug and interferon combinations, Vol. II, 29
Hartshorn, 1987, Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha a interferon, Antimicrob. Agents Chemother., 31, 168, 10.1128/AAC.31.2.168
Huggins, 1984, Synergistic antiviral eftects of ribavirin and the c-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses, Antimicrob. Agents Chemother., 26, 476, 10.1128/AAC.26.4.476
Hunt, 1986, Percent agreement, Pearson's correlation, and kappa as measures of inter-examiner reliability, J. Dent. Res., 65, 128, 10.1177/00220345860650020701
Jackson, 1984, A kinetic model of regulation of the deoxyribonucleoside triphosphate pool composition, Pharmac. Ther., 24, 279, 10.1016/0163-7258(84)90038-X
Jawetz, 1968, The use of combinations of antimicrobial drugs, Ann. Rev. Pharmacol., 8, 151, 10.1146/annurev.pa.08.040168.001055
Johnson, 1987, Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds, Intervirology, 28, 89, 10.1159/000150000
Karlsson, 1988, Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1, Antimicrob. Agents Chemother., 32, 1100, 10.1128/AAC.32.7.1100
Kirsi, 1984, Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin, Antimicrob. Agents Chemother., 26, 466, 10.1128/AAC.26.4.466
Klein, 1975, Isolation of herpes simplex virus clones and drug resistant mutants in microcultures, Arch. Virol., 49, 73, 10.1007/BF02175598
Lam, 1987, The interaction of radiations of different LET, Phys. Med. Biol., 32, 1291, 10.1088/0031-9155/32/10/008
Landini, 1983, A rapid antiviral drug test by enzyme-linked immunoassay, Diag. Immunol., 1, 284
Langlois, 1986, A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs, J. Biol. Stand., 14, 201, 10.1016/0092-1157(86)90004-1
Loewe, 1928, Die Quantitations probleme der Pharmakologie, Ergebn. Physiol., 27, 47, 10.1007/BF02322290
Loewe, 1938, Coalative actions of combined drugs, J. Pharmacol., 63, 24
Loewe, 1953, The problem of synergism and antagonism of combined drugs, Arzneim. Forsch., 3, 285
Loewe, 1954, Potentiation of drug-produced ejaculation by β-diethylaminoethyldiphenylpropylacetate (SKF No. 525A), J. Pharmacol., 110, 271
Loewe, 1957, Antagonism and antagonists, Pharmacol. Rev., 9, 237
London, 1982, Application of response surface methodology to the assay of gamma-glutamyltransferase, Clin. Chem., 5, 1140, 10.1093/clinchem/28.5.1140
MacKay, 1981, An analysis of functional antagonism and synergism, Br. J. Pharmacol., 73, 127, 10.1111/j.1476-5381.1981.tb16781.x
Maddox, 1977, Use of response surface methodology for the rapid optimalization of microbiological media, J. Appl. Bacteriol., 43, 197, 10.1111/j.1365-2672.1977.tb00743.x
Mead, 1975, A review of response surface methodology from a biometric viewpoint, Biometrics, 31, 803, 10.2307/2529809
Palatini, 1982, The interaction between full and partial inhibitors acting on a single enzyme, A theoretical analysis. Mol. Pharmacol., 24, 30
Potmesil, 1986, Effects of N-trifluoroacetyladriamycin-14-O-hemiadipate and radiation on L1210 cells, Rad. Res., 105, 147, 10.2307/3576540
Rabalais, 1987, Rapid herpes simplex susceptibility testing using an enzyme-linked immunosorbant assay performed in situ on fixed virus infected monolayers, Antimicrob. Agents Chemother., 31, 946, 10.1128/AAC.31.6.946
Sandstrom, 1987, Antiviral therapy in AIDS clinical pharmacological properties and therapeutic experience to date, Drugs, 34, 372
Schinazi, 1986, Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis, Antimicrob. Agents Chemother., 30, 491, 10.1128/AAC.30.3.491
Shipman, 1969, Evaluation of 4-(2-hydroxyethyl)-1-piperazineëthanesulfonic acid (HEPES) as a tissue culture buffer, 130, 305
Skipper, 1974, Combination therapy: some concepts and results, Can. Chemother. Rep., 4, 137
Solana, 1986, Estimation and testing of the concentration-response surfaces associated with multiple agent combinations, Toxicol. App. Pharmacol., 85, 231, 10.1016/0041-008X(86)90117-1
Spector, 1985, Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition, 82, 4254
Spector, 1989, 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir, 86, 1051
Steel, 1979, Exploitable mechanisms in combined radiotherapy- chemotherapy: the concept of additivity, J. Radiation Oncol. Biol. Phys., 5, 85, 10.1016/0360-3016(79)90044-0
Streifel, 1981, Synergistic interaction between 1-β-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro, 78, 5132
Sühnel, 1990, Evaluation of synergism and antagonism for the combined action of antiviral agents, Antiviral Res., 13, 23, 10.1016/0166-3542(90)90042-6
Turk, 1986, Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivitives of 2-acetylpyridine thiosemicarbazone, Biochem. Pharmacol., 35, 1539, 10.1016/0006-2952(86)90122-X
Turk, 1986, Structure activity relationships among α-(N)-heterocyclic acyl thiosemicarbazones and related compounds as inhibitors of herpes simplex virus type 1 specified ribonucleoside diphosphate reductase, J. Gen. Virol., 67, 1625, 10.1099/0022-1317-67-8-1625
Veldstra, 1956, Synergism and potentiation with special reference to the combination of structural analogues, Pharmacol. Rev., 8, 339
Voght, 1987, Ribaviroin antagonizes the effect of azidothymidine on HIV replication, Science, 235, 1376, 10.1126/science.2435003
Webb, 1963, Vol. 1, 55
Webb, 1963, Vol. 1, 488